Welcome to LookChem.com Sign In|Join Free
  • or
(±)-4-((tert-butyldiphenylsilyl)oxy)piperidin-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

476014-77-4

Post Buying Request

476014-77-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

476014-77-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 476014-77-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,6,0,1 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 476014-77:
(8*4)+(7*7)+(6*6)+(5*0)+(4*1)+(3*4)+(2*7)+(1*7)=154
154 % 10 = 4
So 476014-77-4 is a valid CAS Registry Number.

476014-77-4Relevant academic research and scientific papers

OXAZOLIDONE COMPOUND, PREPARING METHOD AND APPLICATION THEREOF

-

Paragraph 0241; 0242; 0243, (2015/12/08)

The present invention relates to the field of a pharmaceutical compound, and more specifically, relates to a new oxazolidone compound, an enantiomer, a diastereoisomer and a raceme thereof, and a mixture thereof, and a pharmaceutically acceptable salt thereof, a preparation method thereof, an application thereof as a bioactive substance in a drug. The compound in the present invention has strong anticoagulant activity, does not affect the activity of thrombin, and can reduce the risk of hemorrhage. A pharmacokinetics experiment shows that the compound in the present invention further has good metabolic characteristics, and has a far better oral bioavailability than a positive contrastive agent rivaroxaban.

PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS

-

Page/Page column 105, (2015/02/02)

The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitors of the complement alternative pathway, in particular of Factor B. The present invention further p

Stereoselective synthesis of (2S,4R)-4-hydroxypipecolic acid

Occhiato, Ernesto G.,Scarpi, Dina,Guarna, Antonio

, p. 524 - 531 (2008/09/18)

A new synthetic route to enantiopure (2S,4R)-4-hydroxypipecolic acid from commercial ethyl (3S)-4-chloro-3-hydroxybutanoate is reported. The synthesis is based on the Pd-catalyzed methoxycarbonylation of a 4-alkoxy-substituted δ-valerolactam-derived vinyl triflate followed by the stereocontrolled hydrogenation of the enamine double bond. The final product was obtained after exhaustive hydrolysis in 20 % yield over 10 steps. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

A stereodivergent approach to substituted 4-hydroxypiperidines

Vink, Mandy K. S.,Schortinghuis, Christien A.,Luten, Jordy,Van Maarseveen, Jan H.,Schoemaker, Hans E.,Hiemstra, Henk,Rutjes, Floris P. J. T.

, p. 7869 - 7871 (2007/10/03)

A stereodivergent route toward both diastereomeric forms of functionalized 4-hydroxypiperidines has been successfully developed. This route involves biocatalytic generation of the enantiopure starting materials followed by functionalization via N-acyliminium ion-mediated CC-bond formation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 476014-77-4